WHWK – whitehawk therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Whitehawk Therapeutics (NASDAQ:WHWK) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.